Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

IMTX — Immatics N.V. SEC Filings | FilingIndex

IMTXNasdaq

Immatics N.V.

Biological Products, (No Diagnostic Substances) · P7 · CIK 1809196

Immatics N.V. develops and commercializes cancer immunotherapies

+ Watch View on EDGAR ↗

$1.28B

Market cap

$10.13

Last close

+6.0%

1D

+2.2%

5D

754K

Volume

Price · last 40 sessions-9.1%

May 4L $8.87 · H $11.62Jun 30

113

Total filings

Jun 18, 2026

Last filing

12/31

Fiscal year end

All 6-K · 91 SC 13G · 8 20-F · 7 424B5 · 6 SC 13D · 1

SC 13DSC 13DJun 6, 2024

Similar companies

Comparable business profile · signals at a glance

IFRXInflaRx N.V.$235.7M-1.8%RCUSArcus Biosciences, Inc.$3.0B-0.8%AGENAGENUS INC$137.4M-2.9%INKTMiNK Therapeutics, Inc.$59.9M-1.9%PTCTPTC THERAPEUTICS, INC.

$6.2B

0.0%

PHVSPharvaris N.V.$2.1B-0.4%